We performed epipharyngeal abrasive therapy (EAT) on 154 patients with chronic epipharyngitis and evaluated subjective symptoms and endoscopic findings. A prospective study by the Epipharyngeal Abrasive Therapy Review Committee is currently being conducted (EATRC study), where endoscopic findings (color tone, swelling, mucous adhesion, and postnasal drip) and bleeding during abrasion are evaluated on a 3-point scale. In a study conducted in 2020 (2020 study), redness (color tone) and swelling were evaluated on a 4-point scale; therefore, we applied this to the evaluation method of the EATRC study to compare the results. The improvement rates of color tone and swelling were 65.8% and 63.0%, respectively, in the 2020 study, and 54.6% and 48.6%, respectively, in the EATRC study. The improvement rate of the total score was 94.2% in the 2020 study and 93.5% in the EATRC study, and the improvement rate of the total score excluding bleeding was 81.8% and 75.3%. In both studies, there was a significant correlation between improvement in the chief complaint and redness, bleeding, and total score. Although bleeding is useful for judging the severity of the disease before treatment, it seems necessary to consider whether to include measuring treatment effect because it disappears or improves after EAT in most cases.
Black spots and granular changes, which are characteristic of nasopharyngeal endoscopic narrow band imaging in chronic epipharyngitis, were also examined on a 3-point scale. Before treatment, the prevalence of black spots and granular changes were 83.8% and 64.3%, respectively, and the improvement rates were 65.9% and 54.8%, respectively.
View full abstract